These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30179443)

  • 41. Temperature-sensitive copolymer-coated fluorescent mesoporous silica nanoparticles as a reactive oxygen species activated drug delivery system.
    Yu F; Wu H; Tang Y; Xu Y; Qian X; Zhu W
    Int J Pharm; 2018 Jan; 536(1):11-20. PubMed ID: 29146540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two-dimensional magnetic WS2@Fe3O4 nanocomposite with mesoporous silica coating for drug delivery and imaging-guided therapy of cancer.
    Yang G; Gong H; Liu T; Sun X; Cheng L; Liu Z
    Biomaterials; 2015 Aug; 60():62-71. PubMed ID: 25985153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted Diagnosis, Therapeutic Monitoring, and Assessment of Atherosclerosis Based on Mesoporous Silica Nanoparticles Coated with cRGD-Platelets.
    Zhang W; Lv Z; Zhang Y; Gopinath SCB; Yuan Y; Huang D; Miao L
    Oxid Med Cell Longev; 2022; 2022():6006601. PubMed ID: 36211824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multifunctional magnetic silica nanotubes for MR imaging and targeted drug delivery.
    Huang L; Ao L; Wang W; Hu D; Sheng Z; Su W
    Chem Commun (Camb); 2015 Mar; 51(18):3923-6. PubMed ID: 25656155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor acidity-activatable manganese phosphate nanoplatform for amplification of photodynamic cancer therapy and magnetic resonance imaging.
    Hao Y; Zheng C; Wang L; Zhang J; Niu X; Song Q; Feng Q; Zhao H; Li L; Zhang H; Zhang Z; Zhang Y
    Acta Biomater; 2017 Oct; 62():293-305. PubMed ID: 28842332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells.
    Kim T; Momin E; Choi J; Yuan K; Zaidi H; Kim J; Park M; Lee N; McMahon MT; Quinones-Hinojosa A; Bulte JW; Hyeon T; Gilad AA
    J Am Chem Soc; 2011 Mar; 133(9):2955-61. PubMed ID: 21314118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hollow manganese oxide nanoparticles as multifunctional agents for magnetic resonance imaging and drug delivery.
    Shin J; Anisur RM; Ko MK; Im GH; Lee JH; Lee IS
    Angew Chem Int Ed Engl; 2009; 48(2):321-4. PubMed ID: 19040234
    [No Abstract]   [Full Text] [Related]  

  • 49. A novel anti-VEGF targeting and MRI-visible smart drug delivery system for specific diagnosis and therapy of liver cancer.
    Huang H; Li Y; Li C; Wang Y; Sun Y; Wang J
    Macromol Biosci; 2013 Oct; 13(10):1358-68. PubMed ID: 23852809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive
    Wei R; Liu K; Zhang K; Fan Y; Lin H; Gao J
    ACS Appl Mater Interfaces; 2022 Jan; 14(3):3784-3791. PubMed ID: 35019261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
    Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracellular antioxidants dissolve man-made antioxidant nanoparticles: using redox vulnerability of nanoceria to develop a responsive drug delivery system.
    Muhammad F; Wang A; Qi W; Zhang S; Zhu G
    ACS Appl Mater Interfaces; 2014; 6(21):19424-33. PubMed ID: 25312332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells.
    Zhao Q; Liu J; Zhu W; Sun C; Di D; Zhang Y; Wang P; Wang Z; Wang S
    Acta Biomater; 2015 Sep; 23():147-156. PubMed ID: 25985912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application.
    Hao Y; Wang L; Zhang B; Li D; Meng D; Shi J; Zhang H; Zhang Z; Zhang Y
    Int J Nanomedicine; 2016; 11():1759-78. PubMed ID: 27199556
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ultrasmall mesoporous organosilica nanoparticles: Morphology modulations and redox-responsive biodegradability for tumor-specific drug delivery.
    Yu L; Chen Y; Lin H; Du W; Chen H; Shi J
    Biomaterials; 2018 Apr; 161():292-305. PubMed ID: 29427925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silica-F127 nanohybrid-encapsulated manganese oxide nanoparticles for optimized T1 magnetic resonance relaxivity.
    Wei Hsu BY; Wang M; Zhang Y; Vijayaragavan V; Wong SY; Yuang-Chi Chang A; Bhakoo KK; Li X; Wang J
    Nanoscale; 2014 Jan; 6(1):293-9. PubMed ID: 24193096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
    Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
    ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemical synthesis and assembly of uniformly sized iron oxide nanoparticles for medical applications.
    Ling D; Lee N; Hyeon T
    Acc Chem Res; 2015 May; 48(5):1276-85. PubMed ID: 25922976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells.
    Liu HM; Wu SH; Lu CW; Yao M; Hsiao JK; Hung Y; Lin YS; Mou CY; Yang CS; Huang DM; Chen YC
    Small; 2008 May; 4(5):619-26. PubMed ID: 18491363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macrophage entrapped silica coated superparamagnetic iron oxide particles for controlled drug release in a 3D cancer model.
    Ullah S; Seidel K; Türkkan S; Warwas DP; Dubich T; Rohde M; Hauser H; Behrens P; Kirschning A; Köster M; Wirth D
    J Control Release; 2019 Jan; 294():327-336. PubMed ID: 30586597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.